Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Hunault

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Transplantation|March 8, 2016
Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive CareCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
European Journal of Haematology|July 14, 2020
Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AMLMyriam Hormi, Rudy Birsen, Maya Belhadj, et al.
European Journal of Haematology|July 10, 2021
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantationsValentin Lacombe, Christopher Nunes Gomes, Jean-Baptiste Robin, et al.
Cancer Gene Therapy|February 23, 2022
Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemiaBenjamin Roux, Frédéric Picou, Christelle Debeissat, et al.
Leukemia & Lymphoma|November 6, 2020
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsMarie-Anne Couturier, Xavier Thomas, Emmanuel Raffoux, et al.
Leukemia|August 12, 2022
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest Against Leukemia (GOAL) studyChristophe Desprez, Jérémie Riou, Pierre Peterlin, et al.
Annals of Hematology|May 3, 2018
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essenceCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang studyEric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Annals of Hematology|October 6, 2021
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosisDamien Luque Paz, Laurane Cottin, Eric Lippert, et al.
BMC Medical Genomics|February 1, 2012
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samplesDiane Raingeard de la Blétière, Odile Blanchet, Pascale Cornillet-Lefèbvre, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Transplantation|March 8, 2016
Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive CareCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
European Journal of Haematology|July 14, 2020
Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AMLMyriam Hormi, Rudy Birsen, Maya Belhadj, et al.
European Journal of Haematology|July 10, 2021
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantationsValentin Lacombe, Christopher Nunes Gomes, Jean-Baptiste Robin, et al.
Cancer Gene Therapy|February 23, 2022
Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemiaBenjamin Roux, Frédéric Picou, Christelle Debeissat, et al.
Leukemia & Lymphoma|November 6, 2020
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsMarie-Anne Couturier, Xavier Thomas, Emmanuel Raffoux, et al.
Leukemia|August 12, 2022
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest Against Leukemia (GOAL) studyChristophe Desprez, Jérémie Riou, Pierre Peterlin, et al.
Annals of Hematology|May 3, 2018
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essenceCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang studyEric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Annals of Hematology|October 6, 2021
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosisDamien Luque Paz, Laurane Cottin, Eric Lippert, et al.
BMC Medical Genomics|February 1, 2012
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samplesDiane Raingeard de la Blétière, Odile Blanchet, Pascale Cornillet-Lefèbvre, et al.
Pageof 13